Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma, Follicular
  • Carcinoma, Papillary
  • Iodine Radioisotopes
  • Neoplasms, Radiation-Induced
  • Neoplasms, Second Primary
  • Thyroid Neoplasms

abstract

  • The increased risk of a SPM in patients with low-risk (T1N0) WDTC, along with a lack of data demonstrating improved survival outcomes with adjuvant RAI, provide a compelling argument in favor of rationing the use of RAI in this patient population.

publication date

  • October 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3155861

Digital Object Identifier (DOI)

  • 10.1002/cncr.26070

PubMed ID

  • 21432843

Additional Document Info

start page

  • 4439

end page

  • 46

volume

  • 117

number

  • 19